UCSF Cancer Center Burlingame is a clinical research site located in Burlingame, California, United States 94010.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
UCSF Cancer Center Burlingame has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Castrate Resistant Prostate Cancer (mCRPC).
Sponsors: Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCSF Cancer Center Burlingame has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCSF Cancer Center Burlingame has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castrate Resistant Prostate Cancer (mCRPC).
UCSF Cancer Center Burlingame has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.